◆英語タイトル：Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	◆商品コード：IMARC23FB0048 ◆発行会社（リサーチ会社）：IMARC ◆発行日：2023年2月1日 ◆ページ数：109 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療

The global dry eye syndrome market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.67% during 2023-2028.

Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global dry eye syndrome market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on disease type, drug type, product and distribution channel.

Breakup by Disease Type:

Evaporative
Aqueous

Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.

Breakup by Drug Type:

Anti-inflammatory Drugs
Lubricant Eye Drops
Autologous Serum Eye Drops

Based on the drug type, anti-inflammatory drugs currently account for the highest market share.

Breakup by Product:

Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Others

Based on the product type, liquid eye drops currently account for the highest market share.

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Based on the distribution channel, hospital pharmacies currently account for the highest market share.

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

On the geographical front, North America currently represents the biggest market for dry eye syndrome.

Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being, Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report
1. What was the size of the global dry eye syndrome market in 2022?
2. What is the expected growth rate of the global dry eye syndrome market during 2023-2028?
3. What are the key factors driving the global dry eye syndrome market?
4. What has been the impact of COVID-19 on the global dry eye syndrome market?
5. What is the breakup of the global dry eye syndrome market based on the disease type?
6. What is the breakup of the global dry eye syndrome market based on the drug type?
7. What is the breakup of the global dry eye syndrome market based on the product?
8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
9. What are the key regions in the global dry eye syndrome market?
10. Who are the key companies/players in the global dry eye syndrome market?